Literature DB >> 35888712

Analyzing and Resolving Infeasibility in Flux Balance Analysis of Metabolic Networks.

Steffen Klamt1, Axel von Kamp1.   

Abstract

Flux balance analysis (FBA) is a key method for the constraint-based analysis of metabolic networks. A technical problem may occur in FBA when known (e.g., measured) fluxes of certain reactions are integrated into an FBA scenario rendering the underlying linear program (LP) infeasible, for example, due to inconsistencies between some of the measured fluxes causing a violation of the steady-state or other constraints. Here, we present and compare two methods, one based on an LP and one on a quadratic program (QP), to find minimal corrections for the given flux values so that the FBA problem becomes feasible. We provide a general guide on how to treat infeasible FBA systems in practice and discuss relevant examples of potentially infeasible scenarios in core and genome-scale metabolic models. Finally, we also highlight and clarify the relationships to classical metabolic flux analysis, where solely algebraic approaches are used to compute unknown metabolic rates from measured fluxes and to balance infeasible flux scenarios.

Entities:  

Keywords:  Escherichia coli; constraint-based modeling; mass balances; metabolic flux analysis; quadratic programming; weighted least-squares

Year:  2022        PMID: 35888712      PMCID: PMC9317134          DOI: 10.3390/metabo12070585

Source DB:  PubMed          Journal:  Metabolites        ISSN: 2218-1989


  20 in total

1.  Calculability analysis in underdetermined metabolic networks illustrated by a model of the central metabolism in purple nonsulfur bacteria.

Authors:  Steffen Klamt; Stefan Schuster; Ernst Dieter Gilles
Journal:  Biotechnol Bioeng       Date:  2002-03-30       Impact factor: 4.530

2.  Linear constraint relations in biochemical reaction systems: I. Classification of the calculability and the balanceability of conversion rates.

Authors:  R T van der Heijden; J J Heijnen; C Hellinga; B Romein; K C Luyben
Journal:  Biotechnol Bioeng       Date:  1994-01-05       Impact factor: 4.530

Review 3.  Use of CellNetAnalyzer in biotechnology and metabolic engineering.

Authors:  Axel von Kamp; Sven Thiele; Oliver Hädicke; Steffen Klamt
Journal:  J Biotechnol       Date:  2017-05-10       Impact factor: 3.307

4.  Analysis of optimality in natural and perturbed metabolic networks.

Authors:  Daniel Segrè; Dennis Vitkup; George M Church
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

5.  Automatic construction of metabolic models with enzyme constraints.

Authors:  Pavlos Stephanos Bekiaris; Steffen Klamt
Journal:  BMC Bioinformatics       Date:  2020-01-14       Impact factor: 3.169

6.  Metabolic flux distributions in Corynebacterium glutamicum during growth and lysine overproduction.

Authors:  J J Vallino; G Stephanopoulos
Journal:  Biotechnol Bioeng       Date:  1993-03-15       Impact factor: 4.530

7.  EColiCore2: a reference network model of the central metabolism of Escherichia coli and relationships to its genome-scale parent model.

Authors:  Oliver Hädicke; Steffen Klamt
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

8.  Improving the phenotype predictions of a yeast genome-scale metabolic model by incorporating enzymatic constraints.

Authors:  Benjamín J Sánchez; Cheng Zhang; Avlant Nilsson; Petri-Jaan Lahtvee; Eduard J Kerkhoven; Jens Nielsen
Journal:  Mol Syst Biol       Date:  2017-08-03       Impact factor: 11.429

9.  Deciphering the physiological response of Escherichia coli under high ATP demand.

Authors:  Simon Boecker; Giulia Slaviero; Thorben Schramm; Witold Szymanski; Ralf Steuer; Hannes Link; Steffen Klamt
Journal:  Mol Syst Biol       Date:  2021-12       Impact factor: 11.429

10.  CNApy: a CellNetAnalyzer GUI in Python for Analyzing and Designing Metabolic Networks.

Authors:  Sven Thiele; Axel von Kamp; Pavlos Stephanos Bekiaris; Philipp Schneider; Steffen Klamt
Journal:  Bioinformatics       Date:  2021-12-08       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.